Cortico Steroids Flashcards
Clinical Indications for Use of
Inhaled Corticosteroids
____ _ ____
COPD
Step 2 asthma
Clinical Indications for Use of
Inhaled Corticosteroids
Step 2 asthma
_____
COPD
Clinical Indications for Use of
Inhaled Corticosteroids
Intranasal aerosol agents:
Management of ? and perennial allergic and
nonallergic rhinitis
seasonal
Clinical Indications for Use of
Inhaled Corticosteroids
Intranasal aerosol agents:
Management of seasonal and ? ? and
nonallergic rhinitis
perennial allergic
Clinical Indications for Use of
Inhaled Corticosteroids
Intranasal aerosol agents:
Management of seasonal and perennial allergic and
____ ______?
nonallergic rhinitis
Most common type of asthma
Allergic
Allergic Asthma
Can be treated with ________
commonly known as allergy shots because
the exact triggering antigen is known.
immunotherapy
Allergic Asthma
Can be treated with immunotherapy
commonly known as ____ ____ because
the exact triggering antigen is known.
allergy shots
Allergic Asthma
Can be treated with immunotherapy
commonly known as allergy shots because
the exact triggering _____ is known.
antigen
Allergic Asthma
Can be treated with immunotherapy
commonly known as allergy shots because
the exact triggering antigen is _____.
KNOWN
Non-allergic asthma:
Triggered by:
_____ ___
Exercise
Stress
Infection
Cold air
Non-allergic asthma:
Triggered by:
Cold air
______
Stress
Infection
Exercise
Non-allergic asthma:
Triggered by:
Cold air
Exercise
_____
Infection
Stress
Non-allergic asthma:
Triggered by:
Cold air
Exercise
Stress
______
Infection
Non-allergic asthma:
No ____ ______ is identified.
No immune response is involved.
Specific Antigen
Non-allergic asthma:
No specific antigen is identified.
No _______ response is involved.
Immune
___-____ asthma:
No specific antigen is identified.
No immune response is involved.
Non-allergic
Phases of the Inflam Response
Early Phase & Late Phase
Phases of the Inflam Response
Early-phase response:
Local vasodilatation
_______ _______ ________
Redness
Increased vascular permeability
Phases of the Inflam Response
Early-phase response:
_____ _______
Increased vascular permeability
Redness
Local vasodilation
Phases of the Inflam Response
____-____response:
Local vasodilatation
Increased vascular permeability
Redness
Early-phase
Phases of the Inflam Response
Early-phase response:
Local vasodilatation
Increased vascular permeability
_______
Redness
Phases of the Inflam Response
Early-phase response:
Local vasodilatation
______ vascular permeability
Redness
Increased
Phases of the Inflam Response
Early-phase response:
Furthermore, in ______ :
Bronchial contraction, wheezing, cough, dyspnea, and hypoxemia as a result of mast cell degranulation and histamine release.
Bronchodilators can reverse bronchospasm
asthma
Phases of the Inflam Response
Early-phase response:
Furthermore, in asthma :
_____ _____, wheezing, cough, dyspnea, and hypoxemia as a result of mast cell degranulation and histamine release.
Bronchial contraction
Phases of the Inflam Response
Early-phase response:
Furthermore, in asthma :
Bronchial contraction, _______, cough, dyspnea, and hypoxemia as a result of mast cell degranulation and histamine release.
wheezing
Phases of the Inflam Response
Early-phase response:
Furthermore, in asthma :
Bronchial contraction, wheezing, _____, dyspnea, and hypoxemia as a result of mast cell degranulation and histamine release.
cough
Phases of the Inflam Response
Early-phase response:
Furthermore, in asthma :
Bronchial contraction, wheezing, cough,______ and hypoxemia as a result of mast cell degranulation and histamine release.
dyspnea,
Phases of the Inflam Response
Early-phase response:
Furthermore, in asthma :
Bronchial contraction, wheezing, cough, dyspnea, and ______ as a result of mast cell degranulation and histamine release.
hypoxemia
Phases of the Inflam Response
Early-phase response:
Furthermore, in asthma :
Bronchial contraction, wheezing, cough, dyspnea, and hypoxemia as a result of ____ ____ ______ and histamine release.
mast cell degranulation
Phases of the Inflam Response
Early-phase response:
Furthermore, in asthma :
Bronchial contraction, wheezing, cough, dyspnea, and hypoxemia as a result of mast cell degranulation and ______ _______
histamine release.
Phases of the Inflam Response
_____-____ response:
Develops 6 to 8 hours later.
Much more difficult to resolve than early-phase
response.
Treatment is aimed at stopping inflammatory
progression before it occurs at this stage.
Hypersecretion of mucus.
Increased vascular permeability.
Late Phase
Phases of the Inflam Response
Late-phase response:
Develops ___-___ ____ later.
Much more difficult to resolve than early-phase
response.
6 to 8 hours
Whats more difficult to resolve
late phase or early phase?
Late Phase
Phases of the Inflam Response
Late-phase response:
_______ of mucus.
Increased vascular permeability
Hypersecretion
Phases of the Inflam Response
Late-phase response:
Treatment is aimed at stopping inflammatory
progression ____ it occurs at this stage.
Before
Phases of the Inflam Response
Late-phase response:
Hypersecretion of mucus.
______ vascular permeability
Increased
Phases of the Inflam Response
Late-phase response:
Hypersecretion of mucus.
Increased vascular_______
permeability
Phases of the Inflam Response
Late-phase response:
Hypersecretion of mucus.
Increased ______ permeability
vascular
Phases of the
Inflamm Response
_____ _____
Leukotrienes and prostaglandins are released.
Mucus plugging.
Phases of the
Inflamm Response
Mucus plugging.
_______ and prostaglandins are released.
Leukotrienes
Phases of the
Inflamm Response
Mucus plugging.
Leukotrienes and ______ are released.
prostaglandins
Phases of the
Inflamm Response
Mucus plugging.
Leukotrienes and prostaglandins are_______
released.
Treatment for allergic asthma.
Blocks the initial immune response and the
_______ process.
inflammatory
Treatment for allergic asthma.
Blocks the initial ____ _____ and the
inflammatory process.
immune response
______: Local dilation of blood
vessels, occurring in seconds
Redness
Redness: Local dilation of blood
vessels, occurring in _____
seconds
_____: Reddish color several
centimeters from the site, occurring
15 to 30 seconds after injury
Flare
Flare: Reddish color several
centimeters from the site, occurring
___-____ seconds after injury
15 to 30
____: Local swelling, occurring in
minutes
Wheal
Wheal: _____ _____, occurring in
minutes
Local swelling
Wheal: Local swelling, occurring in
_____
minutes
______ vascular permeability:
An exudate is formed in the
surrounding tissues
increased
Increased vascular permeability:
An exudate is formed in the
______ _______
surrounding tissues
_______ infiltration: White cells
emigrate through capillary walls
(diapedesis) in response to
attractant chemicals (chemotaxis)
Leukocytic
leukocytic infiltration: ____ ____
emigrate through capillary walls
(diapedesis) in response to
attractant chemicals (chemotaxis)
White cells
leukocytic infiltration: White cells
emigrate through_____ _____
(diapedesis) in response to
attractant chemicals (chemotaxis)
capillary walls
leukocytic infiltration: White cells
emigrate through capillary walls
(_______) in response to
attractant chemicals (chemotaxis)
diapedesis
leukocytic infiltration: White cells
emigrate through capillary walls
(diapedesis) in response to
attractant chemicals (______)
chemotaxis
______: White cells and
macrophages (in the lungs) ingest and
process foreign material such as bacteria
Phagocytosis
Phagocytosis: _______ and
______ (in the lungs) ingest and
process foreign material such as bacteria
White cells; macrophages
Phagocytosis: White cells and
macrophages (in the lungs)_____ and
process foreign material such as bacteria
ingest
_____ _____: Histamine and
chemoattractant factors are released at the
site of injury, and various inflammatory
mediators such as complement and
arachidonic acid products are generated
Mediator cascade
Mediator cascade: _______ and
chemoattractant factors are released at the
site of injury, and various inflammatory
mediators such as complement and
arachidonic acid products are generated
Histamine
Mediator cascade: Histamine and \_\_\_\_\_\_\_ factors are released at the site of injury, and various inflammatory mediators such as complement and arachidonic acid products are generated
chemoattractant
Mediator cascade: Histamine and
chemoattractant factors are released at the
site of injury, and various inflammatory
mediators such as _____ and
arachidonic acid products are generated
complement
Mediator cascade: Histamine and
chemoattractant factors are released at the
site of injury, and various inflammatory
mediators such as complement and
_____ ______ products are generated
arachidonic acid
Most common inflammation in the airway
Chronic Bronchitis
Asthma
Treatment with antiinflammatory agents such as \_\_\_\_\_\_\_ is important to reduce the basal level of airway inflammation and thereby reduce airway hyperresponsiveness and the predisposition to acute episodes of obstruction
glucocorticoids
Treatment with antiinflammatory agents such as glucocorticoids is important to reduce the \_\_\_\_\_ level of airway inflammation and thereby reduce airway hyperresponsiveness and the predisposition to acute episodes of obstruction
basal
Treatment with antiinflammatory agents such as glucocorticoids is important to reduce the basal level of airway inflammation and thereby reduce airway \_\_\_\_\_\_\_\_ and the predisposition to acute episodes of obstruction
hyperresponsiveness
Treatment with antiinflammatory agents such as glucocorticoids is important to reduce the basal level of airway inflammation and thereby reduce airway hyperresponsiveness and the \_\_\_\_\_\_\_ to acute episodes of obstruction
predisposition
Treatment with antiinflammatory agents such as glucocorticoids is important to reduce the basal level of airway inflammation and thereby reduce airway hyperresponsiveness and the predisposition to \_\_\_\_\_ episodes of obstruction
acute
Assess for presence of side effects of inhaled
steroid therapy
Oral thrush Hoarseness Voice changes cough/wheezing with MDI Use of reservoir with MDI
killl meeee
Assess for presence of side effects of inhaled
______ therapy
Oral thrush Hoarseness Voice changes cough/wheezing with MDI Use of reservoir with MDI
steroid
Assess for presence of side effects of inhaled
steroid therapy
\_\_\_\_\_ \_\_\_\_\_ Hoarseness Voice changes cough/wheezing with MDI Use of reservoir with MDI
Oral thrush
Assess for presence of side effects of inhaled
steroid therapy
Oral thrush Hoarseness \_\_\_ \_\_\_\_\_\_\_ cough/wheezing with MDI Use of reservoir with MDI
Voice changes
Assess for presence of side effects of inhaled
steroid therapy
Oral thrush \_\_\_\_\_\_\_ Voice changes cough/wheezing with MDI Use of reservoir with MDI
Hoarseness
Assess for presence of side effects of inhaled
steroid therapy
Oral thrush Hoarseness Voice changes \_\_\_\_\_\_/\_\_\_\_ with MDI Use of reservoir with MDI
cough/wheezing
Assess for presence of side effects of inhaled
steroid therapy
Oral thrush Hoarseness Voice changes cough/wheezing with MDI Use of \_\_\_\_\_\_ with MDI
reservoir
_______ Side effects
Renal insufficiency Extrapulmonary allergy Acute asthma HPA suppression (minimal) Growth retardation Osteoporosis
SYSTEMIC
SYSTEMIC
\_\_\_\_\_ \_\_\_\_\_\_\_ Extrapulmonary allergy Acute asthma HPA suppression (minimal) Growth retardation Osteoporosis
Renal insufficiency
SYSTEMIC
Renal insufficiency Extrapulmonary allergy \_\_\_\_\_ asthma HPA suppression (minimal) Growth retardation Osteoporosis
Acute
SYSTEMIC
Renal insufficiency \_\_\_\_\_\_ allergy Acute asthma HPA suppression (minimal) Growth retardation Osteoporosis
Extrapulmonary
SYSTEMIC
Renal insufficiency Extrapulmonary allergy Acute asthma \_\_\_\_suppression (minimal) Growth retardation Osteoporosis
HPA
SYSTEMIC
Renal insufficiency Extrapulmonary allergy Acute asthma HPA \_\_\_\_\_\_\_\_ (minimal) Growth retardation Osteoporosis
suppression
SYSTEMIC
Renal insufficiency Extrapulmonary allergy Acute asthma HPA suppression (\_\_\_\_\_) Growth retardation Osteoporosis
minimal
SYSTEMIC
Renal insufficiency Extrapulmonary allergy Acute asthma HPA suppression \_\_\_\_ \_\_\_\_\_\_\_\_ Osteoporosis
Growth retardation
SYSTEMIC
Renal insufficiency Extrapulmonary allergy Acute asthma HPA suppression (\_\_\_\_\_) Growth retardation \_\_\_\_\_\_\_\_\_
Osteoporosis
______ Side Effects
Oropharyngeal fungal infections
Dysphonia
Cough, bronchoconstriction
Incorrect use of MDI
LOCAL
LOCAL Side Effects
_______ fungal infections
Dysphonia
Cough, bronchoconstriction
Incorrect use of MDI
Oropharyngeal
LOCAL Side Effects
Oropharyngeal fungal infections
________
Cough, bronchoconstriction
Incorrect use of MDI
Dysphonia
LOCAL Side Effects
Oropharyngeal ______ infections
Dysphonia
Cough, bronchoconstriction
Incorrect use of MDI
fungal
LOCAL Side Effects
Oropharyngeal fungal infections
Dysphonia
Cough, __________
Incorrect use of MDI
bronchoconstriction
LOCAL Side Effects
Oropharyngeal fungal infections
Dysphonia
______, bronchoconstriction
Incorrect use of MDI
Cough
LOCAL Side Effects
Oropharyngeal fungal infections
Dysphonia
Cough, bronchoconstriction
_____ use of MDI
Incorrect
LOCAL Side Effects
Oropharyngeal fungal infections
Dysphonia
Cough, bronchoconstriction
Incorrect use of ____
MDI
_____ suppression not seen in doses
< 800 ug
Adrenal
Adrenal _______ not seen in doses
< 800 ug
suppression
Adrenal suppression not seen in doses
< ____ __
800 ug
Evidence of a beneficial, ___________
interaction between glucocorticoids and β-
adrenergic agonists
complementary
Evidence of a beneficial, complementary
interaction between_______ and β-
adrenergic agonists
glucocorticoids
Evidence of a beneficial, complementary
interaction between glucocorticoids and____-_____ ______
β-adrenergic agonists
_____ increase β2-adrenergic receptor
transcription
Steroids
Steroids_____ β2-adrenergic receptor
transcription
increase
Steroids increase____-_____ receptor
transcription
β2-adrenergic
steroids increase β2-adrenergic receptor
______
transcription
______ corticosteroid therapy can provide
partial protection against development of
tolerance
Inhaled
Inhaled corticosteroid therapy can provide
_____ _____ against development of
tolerance
partial protection
Inhaled corticosteroid therapy can provide
partial protection against development of
_____
tolerance
_______ has been shown to promote
binding of the glucocorticoid receptor to the
response element of the cell’s nuclear DNA
Salmeterol
Salmeterol has been shown to promote
_____ of the glucocorticoid receptor to the
response element of the cell’s nuclear DNA
binding
Salmeterol has been shown to promote
binding of the_______ receptor to the
response element of the cell’s nuclear DNA
glucocorticoid
Salmeterol has been shown to promote
binding of the glucocorticoid receptor to the
response element of the cell’s ____ _____
nuclear DNA
Salmeterol has been shown to promote
binding of the glucocorticoid receptor to the
______ element of the cell’s nuclear DNA
response
______ corticosteroids
All of the steroids available as orally
inhaled agents are also available in an
intranasal formulation
Intranasal
Intranasal corticosteroids
All of the steroids available as____ ____
agents are also available in an
intranasal formulation
orally
inhaled
Used for treatment of allergic or inflammatory nasal conditions and seasonal or perennial allergic or nonallergic rhinitis and to prevent reoccurrence of nasal polyps
Intranasal corticosteroids
Systemic administration of ______
Suppression of the HPA axis immunosuppression Psychiatric reactions Cataract formation Myopathy of striated skeletal muscle Peptic ulcer
steroids
Systemic administration of steroids
Suppression of the\_\_\_ \_\_\_ immunosuppression Psychiatric reactions Cataract formation Myopathy of striated skeletal muscle Peptic ulcer
HPA axis
Systemic administration of steroids
Suppression of the HPA axis \_\_\_\_\_\_\_\_\_ Psychiatric reactions Cataract formation Myopathy of striated skeletal muscle Peptic ulcer
immunosuppression
Systemic administration of steroids
Suppression of the HPA axis immunosuppression \_\_\_\_\_\_ reactions Cataract formation Myopathy of striated skeletal muscle Peptic ulcer
Psychiatric
Systemic administration of steroids
Suppression of the HPA axis immunosuppression Psychiatric reactions Cataract formation Myopathy of striated skeletal muscle \_\_\_\_ \_\_\_\_
Peptic ulcer
Systemic side effects with _____
administration
Of major concern:
HPA suppression
Loss of bone density
Growth restriction in children
aerosol
Systemic side effects with aerosol
administration
Of major concern:
____ ______
Loss of bone density
Growth restriction in children
HPA suppression
Systemic side effects with aerosol
administration
Of major concern:
HPA suppression
_____ ___ ____ ____
Growth restriction in children
Loss of bone density
Systemic side effects with aerosol
administration
Of major concern:
HPA suppression
Loss of bone density
_____ _____ _____ _____
Growth restriction in children
Clinical Application of Aerosol
_____
Use in asthma
Early use in asthma
For acute severe asthma
Clinical use of inhaled corticosteroids
Steroids
Clinical Application of Aerosol Steroids Use in\_\_\_\_\_ Early use in asthma For acute severe asthma Clinical use of inhaled corticosteroids
asthma
Clinical Application of Aerosol Steroids Use in asthma Early use in asthma For acute severe asthma Clinical use of inhaled \_\_\_\_\_\_
corticosteroids
Clinical Application of Aerosol
Steroids
Use in _____
Relieves symptoms
Little or no effect on FEV1
COPD
Clinical Application of Aerosol
Steroids
Use in copd
Relieves symptoms
Little or no effect on _____
FEV!
Inahled corticosteroid
Controller or Rescue
Controller
Steroid Dependency
Classified into two forms:
Physiologic - Psychological
___________—Desire occurs because of an
induced sense of well-being or effective
symptom relief when taking the drug.
Psychological
________ —Steroid suppression of the
normal functions of the HPA occurs when
a patient is withdrawn from steroids too
quickly.
Physiologic